A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers
- PMID: 8875984
A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers
Abstract
All isoforms of the Wilms' tumour suppressor protein, WT1, contain four consecutive zinc fingers which facilitate DNA binding. The predominant WT1 transcript contains a 9 base pair insertion resulting in an additional three amino acids, lysine-threonine-serine (KTS), between zinc fingers 3 and 4. WT1 zinc fingers 2, 3 and 4 are highly homologous to the zinc fingers of the early growth response gene, EGR1. However, only WT1--KTS is capable of binding an EGR1 consensus site. In contrast, the previously described genomic fragment, +P5 (D1S3309E), is bound by both WT1--KTS and WT1 + KTS. In this study, the region within + P5 to which both WT1 -- KTS and WT1 + KTS bind was defined as 5'-GGAGAGGGAGGATC-3'. EGR1 did not bind + P5. By creating zinc finger deletions, we demonstrate that zinc finger 1, but not zinc finger 4, is critical for + P5 binding; whereas zinc finger 4, but not 1, is necessary for the binding of WT1 target sites within EGR1, PDGF A chain and IGF2 promoters. Thus, zinc finger usage can vary with target and + P5 may represent a novel type of WT1 binding site, the physiological relevance of which must be investigated.
Similar articles
-
Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.Oncogene. 1995 Feb 2;10(3):415-22. Oncogene. 1995. PMID: 7845666
-
Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1.Biochemistry. 1998 Feb 17;37(7):2051-8. doi: 10.1021/bi9717993. Biochemistry. 1998. PMID: 9485332
-
Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.Biochemistry. 1996 Sep 17;35(37):12070-6. doi: 10.1021/bi960758o. Biochemistry. 1996. PMID: 8810912
-
WT1: what has the last decade told us?Bioessays. 1999 Mar;21(3):191-202. doi: 10.1002/(SICI)1521-1878(199903)21:3<191::AID-BIES3>3.0.CO;2-8. Bioessays. 1999. PMID: 10333728 Review.
-
Wilms tumor and the WT1 gene.Exp Cell Res. 2001 Mar 10;264(1):74-99. doi: 10.1006/excr.2000.5131. Exp Cell Res. 2001. PMID: 11237525 Review.
Cited by
-
Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype.Br J Cancer. 1998;77(2):253-9. doi: 10.1038/bjc.1998.41. Br J Cancer. 1998. PMID: 9460996 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous